Post on 05-Apr-2018
7/31/2019 Faculty Strategic Plan
1/90
)20152010(
1
7/31/2019 Faculty Strategic Plan
2/90
7/31/2019 Faculty Strategic Plan
3/90
231995
1994/1995
.
)2(
.
2004/2005
.
-2004
CIQAP
.
3
7/31/2019 Faculty Strategic Plan
4/90
-" "
CIQAP
.
-.
-
.( )
-.
-
.
-
.
-)
( ) (
-.
-.
-.
-
.
-.
-.
:
4
7/31/2019 Faculty Strategic Plan
5/90
.
:
:
.
.
.
. ,
, , ,
,
,
.
:
5
7/31/2019 Faculty Strategic Plan
6/90
1-
:
1-.
2-.
3-.
2-
.
3-
/
51/33%
50/32.5%
16/10%
31/20%
7/4.5%
4-
/
17/40%
6/14.5%
5/12%6
7/31/2019 Faculty Strategic Plan
7/90
4/9.5%
3/7%
6/14.5%
1/2.5%
5-
.
6-205
19/10/2009.
:
1-
.
2-5.
7
7/31/2019 Faculty Strategic Plan
8/90
SWOT Analysis
.
:
1-.
2-.
3-
/
18/34.5%
14/27%
4/7.5%
9/17.5%
7/13.5%
4-
8
7/31/2019 Faculty Strategic Plan
9/90
/
17/40%
6/14.5%
5/12%
4/9.5%
3/7%
6/14.5%
1/2.5%
5-.
6-.
7-205
19/10/2009.
9
7/31/2019 Faculty Strategic Plan
10/90
7/31/2019 Faculty Strategic Plan
11/90
7/31/2019 Faculty Strategic Plan
12/90
:
.
Opportunities:
.
.
DAAD) Deutscher Akademischer Austausch
Dienst(Deutsche Forschungsgemeinschaft (DFG(
.
.
.
.
Threats:
.
.
.
.
.
.
.
:1-
2-
3-4-
12
7/31/2019 Faculty Strategic Plan
13/90
5-6-7-
:
1-
2-
3-
4-
5-
-:1: -
%
%( )
90%
90%0.810.15
.
90
%
90%0.810.1
5.85
%85%0.720.1
3
.90%
95%0.860.16
20082012.
95%
95%0.90.17
( )
60
%
40%0.240.0
4
.65%
45%0.290.05
.
35%
60%0.210.04
.
30%
65%0.190.04
30%
50%0.150.03
3055%0.160.0
13
7/31/2019 Faculty Strategic Plan
14/90
.%35.341.0
0
2: -
( )
0.15
40.6
.
0.1
5
30.45
.0.13
20.26
.
0.16
40.64
20082012.
0.17
50.85
( )
0.0
4
10.04
.
0.05
10.05
.
0.04
10.04
.
0.04
10.04
0.03
10.03
.
0.03
10.03
14
7/31/2019 Faculty Strategic Plan
15/90
1.00
3.00
.
15
7/31/2019 Faculty Strategic Plan
16/90
3: -
32-132-1220330
32-132-132-1
32-132-1
32-1220
32-132-1
220
:
:( - - )
:( - - )
:( - )
16
7/31/2019 Faculty Strategic Plan
17/90
-:
1: -
%
%
( )
50%
85%0.430.1
.
60%
65%0.390.09
DAADDFG65%
70%0.450.11
.
65%
70%0.450.11
.
90%
90%0.810.19
( )
.
85
%
40%0.340.0
8
.
60%
50%0.300.07
.90%
40%0.360.08
.
55%
60%0.330.08
.
65%
50%0.330.08
4.191.00
17
7/31/2019 Faculty Strategic Plan
18/90
7/31/2019 Faculty Strategic Plan
19/90
19
7/31/2019 Faculty Strategic Plan
20/90
7/31/2019 Faculty Strategic Plan
21/90
5..6.
.7..
)T()S + T( ) ()W + T(( )
.1..2.
.3..
1..
.
.
.
.
( )
2,3
7/31/2019 Faculty Strategic Plan
22/90
7/31/2019 Faculty Strategic Plan
23/90
7/31/2019 Faculty Strategic Plan
24/90
.
7/31/2019 Faculty Strategic Plan
25/90
1.
.
2.
57357)3. (
3.P C R
.
4.:
)4.(
-
)5.(
.
5." "
.
6..
7.2010-
2011.
7/31/2019 Faculty Strategic Plan
26/90
::::
:::
:
1..
2.
.
3.
.
7/31/2019 Faculty Strategic Plan
27/90
4.
.
:
1..
2..
3.
)NARS. (
4.
.
5..
6.
7..
7/31/2019 Faculty Strategic Plan
28/90
8..
9..
10..
11..
12..
13..
14.
.
15..
16.
.
1-
1-.
2-.
3-)NARS(
7/31/2019 Faculty Strategic Plan
29/90
.
.4-
.5. -6-
.
2-
.
7-
8. -9-
.
3-
.
10-.
11. -12. -13. -14-
.
4-
15-16-
.
:
1-
:
1-.
7/31/2019 Faculty Strategic Plan
30/90
2-.
3-
.
2-
.
3-
/
18/55%
3/9%
4/12%
2/6%
6/18%
4-211
11/1/2010.
7/31/2019 Faculty Strategic Plan
31/90
:
1-
:
1-.
2-.
3-.
4-.
1-
.
2-
/
23/65.5%
5/14.5%2/5.5%
5/14.5%
3-21111/1/2010.
7/31/2019 Faculty Strategic Plan
32/90
:
1-.
-.
1-
.
-.
2-
-:
.
.
.
4-
-
7/31/2019 Faculty Strategic Plan
33/90
7/31/2019 Faculty Strategic Plan
34/90
4
.
:
:
NARS
2025%25%
4045%35%
1723%17%
48%12%
510%6%
25%2%
25%3%
:
7/31/2019 Faculty Strategic Plan
35/90
:
:
:
( )
::
7/31/2019 Faculty Strategic Plan
36/90
:
.
:
.
7/31/2019 Faculty Strategic Plan
37/90
:
1-
.
2-.
3-.
4-.
5-.
6-)218
31/5/2010(
7-.
7/31/2019 Faculty Strategic Plan
38/90
:
1-
-
.
2-
-
.
7/31/2019 Faculty Strategic Plan
39/90
7/31/2019 Faculty Strategic Plan
40/90
)Objectives-:(
1-
2-
3-
.4-
.
5-
.
6-.7-
.
)policies-:(
1-.
2-
)Impact Factor(
7/31/2019 Faculty Strategic Plan
41/90
3-
.
4-
.
5-
.
)Action plan-: (
1-
2-
.
3-
4-
.
5-
.
) -:Responsibilities-: (
1-/ .
2-
3-
.
7/31/2019 Faculty Strategic Plan
42/90
4-( )
.
)Funding-:(
1-
2-CIQAP
3-
.
4-.
)Indicators-:(
1-.
2-.
3-
.
4-7.
5-.
6-
.
) -:Research items-:(
:
.
-
Under the theme of towards Safe and active of drugs
7/31/2019 Faculty Strategic Plan
43/90
-
.
-
.
-
. / / /
-Production of new drug delivery systems treatment of
gnendisfunction related diseases and DNA vaccination as part of
cooperation in biotechnological field.
-Production of different dosage forms carrying drugs and
measuring the clinical efficacy of these forms on volunteers.
Comparing the newly produced dosage forms to what available in
market regarding bioavailability, clinical efficacy and toxicity.
-Quantitative estimation of natural compounds in pharmaceutical
products, stability and bioequivalence standards.
-Pharmaceutical effects of gum Arabic.
-Biological activities of medicinal plants pure compounds and its
extracts.
-Antimicrobial activities of pure compounds and medicinal plant
extracts
-Mutagenicity and carcinogenicity of medicinal herbal plant
extracts.
7/31/2019 Faculty Strategic Plan
44/90
-Genetic manipulation of medicinal plants to enhance or modulate
the production of important active constituents.
-
.
.
.
-Applied and Environmental Microbiology: the department aims to
study the environmental risks and hazards on the surrounding
society in the Helwan area, which serves a large sector of the
population in Helwan governorate. Currently, a research project
deals with the microbiological analysis of drinking water.
-Biotechnology: this field of research utilizes bacteria like
Escherichia coli to produce valuable pharmaceutical products with
the least costs possible. The results of research studies can be
applied in industry to produce the desired product on the industrial
scale. The research work accomplished in a master's thesisoptimized the fermentation conditions that could be applied to
increase the production of liquid crystalline polymers.
-Clinical and pharmaceutical microbiology: the department is
interested in studying the rates of bacterial resistance to antibiotics
in the clinical settings (public hospital in Helwan and teaching
hospitals in other areas in Cairo). The outcome of research studies
will help determine the reason of treatment failure using antibiotics
(elucidate the mechanism of bacterial resistance to antibiotics). As
a result, clinicians will be able to decide what appropriate
treatment regimen to be used; thus reduce healthcare costs and
economic burden on the healthcare sector. Knowing the effective
treatment helps alleviate the pain and suffering of patients and
7/31/2019 Faculty Strategic Plan
45/90
7/31/2019 Faculty Strategic Plan
46/90
3-
.
4-.
5-.
6-
.
7-
.
8-.
9-
.
10-)
21315/2/2010.(
11-.
:
1-
-
7/31/2019 Faculty Strategic Plan
47/90
7/31/2019 Faculty Strategic Plan
48/90
2008/2012
:
7/31/2019 Faculty Strategic Plan
49/90
7/31/2019 Faculty Strategic Plan
50/90
:
1..2.
3.4.
:
1. .
2.
.
:
1.:
2.:
2008
2012
7/31/2019 Faculty Strategic Plan
51/90
7/31/2019 Faculty Strategic Plan
52/90
:
: :
:
1..
2.)( ----
.3.
.4..5..6.
7..
8..
: :
1..
2..3..4.5..6.
.7..8.Data Show.
7/31/2019 Faculty Strategic Plan
53/90
:
1..2..
3. 4..5.
.
:
:
1..
2.
3..4..
5..
6..
7..
8..
7/31/2019 Faculty Strategic Plan
54/90
7/31/2019 Faculty Strategic Plan
55/90
7/31/2019 Faculty Strategic Plan
56/90
.
+
2008-
2012
200,000
)
+(
2008-2008
150,000
2008-2010
500,000
7/31/2019 Faculty Strategic Plan
57/90
+ +
2008-2010
400,000
+ +
2008-
2012
250,000
.
+ +2008-
2012150,000
7/31/2019 Faculty Strategic Plan
58/90
.+ +
2008-2012
100,000
+
++
2008-2009
100,000
+
++
2008-2012
125,000
+
+
2008-2009
65,000
7/31/2019 Faculty Strategic Plan
59/90
+
+
++
2008-2010
30,000
.
+
++
2008-2010
24,000
.
+
++
2008-2010
100,000
+
++
2008-2012
150,000
7/31/2019 Faculty Strategic Plan
60/90
+
++
2008-2012
1,000,000
1,750,000
1,594,000
3,344,000
7/31/2019 Faculty Strategic Plan
61/90
:
1.
2.3.
.4.
.5..6..7.
. 8..9.
.
:
1-
7/31/2019 Faculty Strategic Plan
62/90
-
)
(
)
(-
2-
-
:
1-
7/31/2019 Faculty Strategic Plan
63/90
-
2-
-
3-
-
.
.
7/31/2019 Faculty Strategic Plan
64/90
7/31/2019 Faculty Strategic Plan
65/90
7/31/2019 Faculty Strategic Plan
66/90
2010 - 2015
7/31/2019 Faculty Strategic Plan
67/90
-:
2 20
2010
1
2 20
2011
2
2 20
2011
3
2 20
2012
4
2 20
2012
5
2 20
2013
6
2 20
2013
7
2 20
2014
8
2 20
2014
9
2 20
2015
10
-
7/31/2019 Faculty Strategic Plan
68/90
**
7/31/2019 Faculty Strategic Plan
69/90
:
. )
. (
:2012
:1-
)SWOT(.
2-.
3-.
7/31/2019 Faculty Strategic Plan
70/90
7/31/2019 Faculty Strategic Plan
71/90
:
CIQA
P1/1
.
/11/1
1-2-
1-
2-
3-
1-2-3-
4-
2011-2011
75,000
25,000
50,00
0
1/1/2
1-2-3-
4-
2010
-
2011
5,000
5,000
1/2
.
1/2/1
.
1-13
CIQAP
1-
40%
1-2-3-
4-
2010
-20113,893,000
2,343,0
00
1,550,000
2-3
2011-2012
900,000
900,000
7/31/2019 Faculty Strategic Plan
72/90
3-4
2012-
2013
1,200,000
1,200,0
00
1/2/2
.
1-2-3-
4-
1-
30%
1-2-3-4-5-6-7-CIQAP
2010
-
2011
150,000
150,00
0
1/2/3
.
1-2-3-4-
1-
10
1-2-
3-
4-
2011-
2013300,000
100,00
0
00,00
0
ouble
ourse
1/2/41-2-
1-
1-2-
2010-201275,000
7/31/2019 Faculty Strategic Plan
73/90
.3-
4-
3-4-
35,00
0
40,00
0
1/2/51-2-
3-
4-
1-20%
2-
20%3-
1-2-
3-
2010-
2011
2,000
2,000
1/2/6
1-
2-
.
1-
15%
1-2-
3-
2011-
2011
50,000
10,00
0
40,00
0
1/2/7
1-2-
3-
1-
10%
1-2-
3-
4-
2011-
2011
20,000
20,00
0
7/31/2019 Faculty Strategic Plan
74/90
1/2/8
1-2-
3-4-
1-
2-3-
4-
5-
6-
7-
8-
9-10-11-
1-2-
3-
4-
2010-
2011
50,000
14,50
0
35,500
1/3
)NARS(
1/3/1
)NARS(
1-2-3-4-5-
1-
2-3-
.
1-2-
3-
4-
2011-
2011
20,000
7/31/2019 Faculty Strategic Plan
75/90
)
NARS(
.
5-6-
20,00
0
1/3/2
.
1-
2-3-
1-
CDC
1-
2-
3-4-
5-CDC
2011
-201220,000
20,00
0
ouble
ourse
1/3/3
)
(
1-
2-3-
4-
1-CDC
1-2-3-
4-
5-CDC
2010-
2011
10,000
10,00
0
1/3/4
1-
2-
1-
1-2-3-
2011-
2011
10,000
7/31/2019 Faculty Strategic Plan
76/90
3-
4-
4-
10,00
0
IQAP
1/4
.
1/4/1
1-2-3-
4-
1-5%
2-
20%
1-2-3-
4-
2011-
2012
50,000
0,00
0
1/5
.
.
1/5/11-2-
3-4-
1-10%
2-3-
1-2-3-4-
5-
2011-
2012
50,000
40,00
0
0,00
0
1/5/2
1-2-
3-4-
1-
.2-
1-2-
3-
4-
2011-
2012
100,000
70,000
30,000
7/31/2019 Faculty Strategic Plan
77/90
1/5/31-2-
3-4-
1-2-3-
1-2-
3-4-5-
2010-
2012
100,000
70,00
0
30,000
1/5/41-
1-101-2-
2012-2014
5,0001
5,0001
1/5/51-2-3-
1-1-2-3-4-
2010
-2011
5,000
5,000
1/6
)
Pharm.D(.
)Pharm.D(.
1/6/1
) Pharm.D(.
1-
2-
3-4-5-6-
1-2-
5%
1-2-
3-4-
2012-
2012
50,000
0,00
0
7/31/2019 Faculty Strategic Plan
78/90
7-8-
.
1/6/2.
1-2-
2013-
2013
5,000
5,000
7,155,000
2,904,
500
2,585,
500
,665,0
00
:
.
7/31/2019 Faculty Strategic Plan
79/90
7/31/2019 Faculty Strategic Plan
80/90
7/31/2019 Faculty Strategic Plan
81/90
:
7/31/2019 Faculty Strategic Plan
82/90
CIQAP
3/10
.
.
3/10/1.
1-2-3-4-5-
1-
1-2-
3-
4-
2012-
2012
5,000
2,000
3,000
3/10/2
1-2-
1-
1-2-
2012-
5,000
7/31/2019 Faculty Strategic Plan
83/90
2,000
3,000
3/10/3
1-2-3-4-
5-
1-.
1-2-
3-
4-
2010-
2011
10,000
10,000
3/10/41-2-3-4-5-
1-
2-3-4-
1-2-
3-
4-
2010-2011
10,000
10,000
3/11
.
3/11/1
.
1-2-
3-
4-
5-6-
1-
2-
1-2-
3-
4-
2010-
2013
30,000
10,00010,000
10,000
7/31/2019 Faculty Strategic Plan
84/90
3/12
.
3/12/11-2-
3-4-
1-1-2-
3-4-
2012-2013
50,000
50,000
3/12/2
1-2-
3-4-
1-
10%
1-2-
3-4-
2013-
2014
10,000
10,000
3/12/31-2-
3-4-5-
1-
10%2-
3-
1-2-
3-4-
2013-
2014
5,000
5,000
3/12/41-2-
3-
1-
10%2-
1-2-
3-
2013-
2014
5,000
7/31/2019 Faculty Strategic Plan
85/90
4-5-
3-
4-5,000
3/12/5
1-2-
3-
4-
1-
.
1-2-
3-4-
2013-
2013
3,000
3,000
3/12/61-2-3-
4-
1-1-2-
3-4-
2013-2013
5,000
5,000
3/13
..
3/13/11-2-3-
4-
1-
2-
1-2-
3-4-
2012-2013
3,000
3,000
3/13/2
.
1-2-
3-4-5-
1-
10%2-
3-
1-2-
3-4-
2013-
2014
5,000
5,000
7/31/2019 Faculty Strategic Plan
86/90
3/13/31-2-
3-4-
5-
1-
10%2-
3-
1-2-
3-4-
2013-
2014
3,000
3,000
3/13/41-2-3-
4-
1-.
1-2-
3-4-
2013-2013
5,000
5,000
3/143/14/1
1-2-
3-4-
1-10%
1-2-
3-4-
2013-
2014
10,000
10,000
3/14/2
1-2-
3-4-
1-
10%
1-2-
3-4-
2013-
2014
5,000
5,000
7/31/2019 Faculty Strategic Plan
87/90
7/31/2019 Faculty Strategic Plan
88/90
4/15/2
1-2-3-
4-
5-
1-
1-2-3-
4-5-
2011-2012
6,000
5,0001,000
4/15/31-
2-3-
4-
5-
1-
.
1-2-
3-4-
2011-20113,000
3,000
4/16
.
4/16/1
1-
2-
3-
1-
20%
1-2-3-
4-5-
2011-2011
3,000
3,000
4/16/2
1-
2-
3-
1-
1-
2-3-
4-5-
2012-
2012
5,000
5,000
7/31/2019 Faculty Strategic Plan
89/90
4/163/
1-
2-
3-
4-
1-
2-
3-
20%
1-2-3-
4-5-
2010-
2011
10,000
10,000
33,000
26,0002,0005,000
7,500,000
3,025,500
2,722,500
1,752,000
7/31/2019 Faculty Strategic Plan
90/90